Lung Adenocarcinoma Stage III Clinical Trials
0 recruiting
Showing 1–2 of 2 trials
Recruiting
Not Applicable
SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors
Colon CancerLung Cancer (Diagnosis)Lung Adenocarcinoma+8 more
Barbara Nemesure100 enrolled1 locationNCT07161713
Recruiting
Phase 2
Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma
Lung Adenocarcinoma Stage IIILung Adenocarcinoma Stage IVEGFR Gene Mutation
Shanghai Pulmonary Hospital, Shanghai, China96 enrolled1 locationNCT05503667